T1/T2 glottic cancer managed by external beam radiotherapy: The influence of pretreatment hemoglobin on local control

被引:150
|
作者
Warde, P
O'Sullivan, B
Bristow, RG
Panzarella, T
Keane, TJ
Gullane, PJ
Witterick, IP
Payne, D
Liu, FF
McLean, M
Waldron, J
Cummings, BJ
机构
[1] Univ Toronto, Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Princess Margaret Hosp, Dept Biostat, Toronto, ON M5G 2M9, Canada
[3] Univ Toronto, Princess Margaret Hosp, Dept Surg Oncol, Toronto, ON M5G 2M9, Canada
关键词
glottic cancer; hemoglobin; local control; radiation therapy;
D O I
10.1016/S0360-3016(98)00062-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Pretreatment hemoglobin (Hb) level has been reported to be an important prognostic factor for local control and survival in various malignancies. However, in many settings, the adverse effect of a low Hb may be related to more advanced disease. The purpose of this analysis was to assess the influence of pretreatment Hb on local control in a large series of patients with a localized cancer (T1/T2 glottic cancer, AJCC 1992) treated in a standard fashion. Materials and Methods: Between January 1981 and December 1989, 735 patients (median age 63; 657 males, 78 females) with T1/T2 glottic cancer were treated with radiation therapy (RT). The standard RT prescription was 50 Gy in 20 fractions over 4 weeks (97% of patients). Factors studied for prognostic importance for local failure included pretreatment Hb, age, sex, T category, anterior commissure involvement, subglottic extension, and tumor bulk (presence of visible tumor vs. subclinical disease). Results: With a median follow up of 6.8 years (range 0.2-14.3), 131 patients have locally relapsed for an actuarial 5-year relapse-free rate of 81.7%. The 5-year actuarial survival was 75.8%. The mean pretreatment hemoglobin level was 14.8 g/dl and was similar in all prognostic categories. On multivariate analysis, using the Cox proportional hazards model, pretreatment Hb predicted for local failure after RT. The hazard ratio (HR) for relapse was calculated for various Hb levels. For example, the HR for a Hb of 12 g/dl vs, a Hb of 15 g/dl was 1.8 (95% confidence interval 1.2-2.5). Previously established factors, including gender, T category, subglottic extension, as well as tumor bulk, were also prognostically important for local control. Conclusions: This analysis, in a large number of similarly treated patients, indicates that pretreatment Hb is an independent prognostic factor for local control in patients with T1/T2 carcinoma of the glottis treated with RT. The underlying biology of this observation needs to be explored, and using this information, it may be possible to develop strategies to improve treatment outcome. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:347 / 353
页数:7
相关论文
共 50 条
  • [31] ACR Appropriateness Criteria® Definitive External-Beam Irradiation in Stage T1 and T2 Prostate Cancer
    Nguyen, Paul L.
    Aizer, Ayal
    Assimos, Dean G.
    D'Amico, Anthony V.
    Frank, Steven J.
    Gottschalk, Alexander R.
    Gustafson, Gary S.
    Hsu, I-Chow Joe
    McLaughlin, Patrick W.
    Merrick, Gregory
    Rosenthal, Seth A.
    Showalter, Timothy N.
    Taira, Al V.
    Vapiwala, Neha
    Yamada, Yoshiya
    Davis, Brian J.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (03): : 278 - 288
  • [32] MANAGEMENT OF T1 AND T2 SQUAMOUS-CELL CARCINOMA OF THE GLOTTIC LARYNX
    MENDENHALL, WM
    PARSONS, JT
    MILLION, RR
    MAYO CLINIC PROCEEDINGS, 1992, 67 (07) : 703 - 705
  • [33] Impact of treatment time and smoking on local control and complications in T1 glottic cancer
    van, der Voet, Johannes C.M.
    Keus, Ronald B.
    Hart, Augustinus A.M.
    Hilgers, Frans J.M.
    Bartelink, Harry
    International Journal of Radiation Oncology, Biology, Physics, 42 (02): : 247 - 255
  • [34] Poor local control of ulcerative T1 glottic cancer treated with 2.25-Gy per fraction radiotherapy
    Oie, Yumi
    Itoh, Yoshiyuki
    Kawamura, Mariko
    Takase, Yuuki
    Murao, Takayuki
    Ishihara, Shunichi
    Nomoto, Yoshihito
    Hirasawa, Naoki
    Asano, Akiko
    Yamakawa, Kouji
    Ito, Junji
    Kinoshita, Fumie
    Naganawa, Shinji
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2021, 83 (04): : 811 - 825
  • [35] Establishing current UK radiotherapy treatment volumes and dose for early glottic larynx cancer (T1/T2 N0)
    Chennupati, Jyothsna
    Beasley, Matthew
    Al-Booz, Hoda
    CLINICAL ONCOLOGY, 2019, 31 : E8 - E8
  • [36] The impact of treatment time and smoking on local control and complications in T1 glottic cancer
    van der Voet, JCM
    Keus, RB
    Hart, AAM
    Hilgers, FJM
    Bartelink, H
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (02): : 247 - 255
  • [37] Prognostic factors in patients with T1 glottic cancer treated with radiotherapy
    Mucha-Malecka, A.
    Chrostowska, A.
    Urbanek, K.
    Malecki, K.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (09) : 792 - 804
  • [38] RADIOTHERAPY IN T1 GLOTTIC CANCER: HAVE WE REACHED A CEILING?
    Geropantas, K.
    Loo, S.
    Martin, C.
    Roques, T.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S332 - S332
  • [39] Effect of tumor bulk on local control and survival of patients with T1 glottic cancer
    Reddy, SP
    Mohideen, N
    Marra, S
    Marks, JE
    RADIOTHERAPY AND ONCOLOGY, 1998, 47 (02) : 161 - 166
  • [40] Glottische LarynxkarzinomeTis, T1 und T2 — Langzeitergebnisse nach LaserresektionCO2 laser microsurgery for glottic carcinomaResults in Tis, T1 and T2 tumors
    O. König
    U. Bockmühl
    K. Haake
    HNO, 2006, 54 (2) : 93 - 98